EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Evolution of neurosurgical advances and nuances in medulloblastoma therapy

Julian S Rechberger, Erica A Power, Michael DeCuypere, David J Daniels

Child's Nervous System · 2024

DOI: 10.1007/s00381-023-06239-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Child's Nervous System, 2024. Verfasst von Julian S Rechberger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurologic Surgery, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. Hauptthemen laut MEDLINE: Medulloblastoma, Brain Neoplasms, Cerebellar Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medulloblastoma, the most common malignant brain tumor in children, presents a complex treatment challenge due to its propensity for infiltrative growth within the posterior fossa and its potential attachment to critical anatomical structures. Central to the management of medulloblastoma is the surgical resection of the tumor, which is a key determinant of patient prognosis. However, the extent of surgical resection (EOR), ranging from gross total resection (GTR) to subtotal resection (STR) or even biopsy, has been the subject of extensive debate and investigation within the medical community. Today, the impact of neurosurgical EOR on the prognosis of medulloblastoma patients remains a complex and evolving area of investigation. The conflicting findings in the literature, the challenges posed by critical surrounding anatomical structures, the potential for surgical complications and neurologic morbidity, and the nuanced interactions with molecular subgroups all contribute to the complexity of this issue. As the field continues to advance, the imperative to strike a delicate balance between maximizing resection and preserving quality of life remains central to the management of medulloblastoma patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedulloblastomaBrain NeoplasmsCerebellar NeoplasmsChildHumansQuality of LifeNeurosurgical ProceduresRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Extent of resectionHistoricalIntraoperative MRIMedulloblastomaMolecular subgroupsNeurosurgerySecond-look surgery

Autor:innen und Institutionen

  • Department of Neurologic Surgery, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
  • Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
  • Loyola Stritch School of Medicine, Maywood, IL, 60153, USA.
  • Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 60611, USA.
  • Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
  • Department of Neurologic Surgery, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. Daniels.David@mayo.edu.

Zitieren

APA

Rechberger, J. S., Power, E. A., DeCuypere, M., & Daniels, D. J. (2024). Evolution of neurosurgical advances and nuances in medulloblastoma therapy. Child's Nervous System. https://doi.org/10.1007/s00381-023-06239-x

Vancouver

Rechberger JS, Power EA, DeCuypere M, Daniels DJ. Evolution of neurosurgical advances and nuances in medulloblastoma therapy. Child's Nervous System. 2024. doi:10.1007/s00381-023-06239-x

BibTeX
@article{Rechberger2024,
  author = {Rechberger, Julian S and Power, Erica A and DeCuypere, Michael and Daniels, David J},
  title = {Evolution of neurosurgical advances and nuances in medulloblastoma therapy},
  journal = {Child's Nervous System},
  year = {2024},
  doi = {10.1007/s00381-023-06239-x}
}
Kostenlos starten →